Live from ASCO 2026: Perspectives on AI in oncology

In a special "woman on the street" episode, host Hansa Bhargava, MD, is live at ASCO 2026. She meets with oncology innovators to discuss what lies ahead for AI in the field, and what gives physicians hope for the future. ·       Interview with Amy Comander, MD, DipABLM. 1:39 ·       Interview with Jame Abraham, MD, FACP. 5:02 ·       Interview with Eleonora Teplinsky, MD. 10:19 ·       Interview with Eric K. Singhi, MD. 13:53 ·       Interview with Erin Kobetz, PhD, MPH. 16:57 ·       Interview with Afreen Shariff, MD, MBBS. 19:17 ·       Interview with Sanjay Juneja, MD. 23:10 We'd love to hear from you! Send your comments/questions to Dr. Bhargava at [email protected]. Abraham, Bhargava, Comander, Kobetz and Teplinsky report no relevant financial disclosures. Juneja is the co-founder of TensorBlack and Vice President of Clinical AI Operations at Tempus AI. Shariff reports having consultant roles with Bristol Myers Squibb, Merck and Novartis, and is co-founder of Citrus Oncology. Singhi reports advisory board or consulting roles with AbbVie, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Caris Life Science, Eli Lilly & Co., GSK, Janssen, Novocure, Nuvalent, Nuvation Bio, Regeneron, Roche, Sandoz and Summit; and research funding from Rexanna's Foundation for Fighting Lung Cancer.